Research output per year
Research output per year
Personal profile
Research interests
During my training I pursued my interest in solid tumor oncology and completed several research projects in breast medical oncology, with a specific interest in clinical outcomes in geriatric patients. Although a large number of older adults are diagnosed with breast cancer, these patients are often unfortunately excluded from clinical trials and more research is needed to better understand clinical outcomes and toxicities of novel therapeutics in this population. During my training, I completed a project which examined progression free survival and toxicities of CDK inhibitors in a geriatric population.
Fingerprint
Dive into the research topics where Katherine Clifton is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)
Ademuyiwa, F. O., Northfelt, D. W., O’Connor, T., Levine, E., Luo, J., Tao, Y., Hoog, J., Laury, M. L., Summa, T., Hammerschmidt, T., Guo, Z., Frith, A., Weilbaecher, K., Opyrchal, M., Aft, R., Clifton, K., Suresh, R., Bagegni, N., Hagemann, I. S. & Iglesia, M. D. & 1 others, , Dec 2023, In: npj Breast Cancer. 9, 1, 1.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer
Hensing, W. L., Gerratana, L., Clifton, K., Medford, A. J., Velimirovic, M., Shah, A. N., Amico, P. D., Reduzzi, C., Zhang, Q., Dai, C. S., Denault, E. N., Bagegni, N. A., Opyrchal, M., Ademuyiwa, F. O., Bose, R., Behdad, A., Ma, C. X., Bardia, A., Cristofanilli, M. & Davis, A. A., Aug 15 2023, In: Clinical Cancer Research. 29, 16, p. 3092-3100 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor–Positive (HRþ)/HER2-Negative Metastatic Breast Cancer
Davis, A. A., Luo, J., Zheng, T., Dai, C., Dong, X., Tan, L., Suresh, R., Ademuyiwa, F. O., Rigden, C., Rearden, T. P., Clifton, K., Weilbaecher, K., Frith, A., Tandra, P. K., Summa, T., Haas, B., Thomas, S., Hernandez-Aya, L. F., Peterson, L. L. & Wang, X. & 7 others, , May 1 2023, In: Clinical Cancer Research. 29, 9, p. 1719-1729 11 p.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis
Gerratana, L., Davis, A. A., Velimirovic, M., Clifton, K., Hensing, W. L., Shah, A. N., Dai, C. S., Reduzzi, C., D’Amico, P., Wehbe, F., Medford, A., Wander, S. A., Gradishar, W. J., Behdad, A., Puglisi, F., Ma, C. X., Bardia, A. & Cristofanilli, M., Dec 2023, In: Breast Cancer Research. 25, 1, 112.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis
Krishnamurthy, J., Luo, J., Suresh, R., Ademuyiwa, F., Rigden, C., Rearden, T., Clifton, K., Weilbaecher, K., Frith, A., Roshal, A., Tandra, P. K., Cherian, M., Summa, T., Haas, B., Thomas, S., Hernandez-Aya, L., Bergqvist, M., Peterson, L. & Ma, C. X., Dec 2022, In: npj Breast Cancer. 8, 1, 35.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations